MIRA University of Twente
Scientists & UsersFor the scientific audience Industry & EconomyOpportunities for collaboration Public & MediaTop technology for patients Students & EducationLearn about the Master programmes


1 Sep 2014 - A most influential scientific mind Prof. Gert Storm has been recognized as one of the most influential scientific minds in the field of Pharmacology and Toxicology. By analyzing  data from their Web of Science platform in the period 2002-2012, Thomson Reuters have identified which researchers have produced work that is the most frequently acknowledged by peers. These individuals are influencing the future direction of their research fields, and of the world. Prof. Storm’s  main affiliation is at the University of Utrecht, he holds a part-time position at the University of Twente in the Department of Biomaterials Science and Technology heading the section Targeted Therapeutics. 27 Aug 2014 - CMI-NEN event 2014 & Inaugural lectures Prof.dr. De Geus-Oei & Prof.dr. Slart Yearly Event of the Center for Medical Imaging - North East Netherlands (CMI-NEN) October 30, 2014 at the University of Twente in Enschede. 26 Aug 2014 - Radiation-free method to track suspicious lymph nodes in case of cancer Researchers at the UT Research Institute MIRA have developed a new method for tracing the sentinel lymph node, the node by which you can tell whether a patient's cancer has spread. Martijn Visscher demonstrated that you can find the node using magnetic nanoparticles, a simple set-up and a clever way of measuring. The patented find, which can quickly be put into practice, will prevent patients from being unnecessarily exposed to ionizing radiation. Visscher will obtain his doctoral degree on 27 August.  20 Aug 2014 - Mathieu Odijk receives Veni grant for Microprobe for more accurate measurements in the brain Mathieu Odijk has received a Veni Grant from The Netherlands Organisation for Scientific Research (NWO). The research project “Microprobe for more accurate measurements in the brain” will be conducted in the BIOS Lab-on-a-chip group. 19 Aug 2014 - TLEMsafe: Improving safety and predictability of complex musculoskeletal surgery As the average lifespan increases, the percentage of aged individuals in populations across developed countries is also growing. This means healthcare systems are presented with a higher incidence of complex musculoskeletal pathologies, such as joint deformation and misalignment or bone and soft-tissue cancer, thus the demand for reconstructive orthopaedic operations is correspondingly rising. 19 Aug 2014 - No support for increasing the volume norm for breast cancer surgery The number of breast cancer surgery which a hospital performs yearly does not play a significant role in the chance of survival. This is the conclusion of research of Sabine Siesling from the University of Twente (MIRA institute) and the Comprehensive Cancer Centre (IKNL) which is published in Breast Cancer Research and Treatment. The study was performed together with the Vereniging Samenwerkende Algemene Ziekenhuizen and medical specialists and does not supports the attention given nowadays to the volume norms for treatment of breast cancer. 18 Aug 2014 - Researchers win international Grand Challenge competition

At the 7th World Congress of Biomechanics, a team of researchers from Aalborg University, Radboudumc, Materialise (Leuven, Belgium) and a research group from Prof. Bart Koopman (from the department of Biomedical Engineering at the Twente University) has been awarded the first prize in the Grand Challenge competition. This competition is a worldwide endeavour in which researchers are challenged to predict loads in the knee joint of a patient who has received a total knee replacement.

11 Aug 2014 - Veni grant for Ruchi Bansal for the development of targeted nano therapeutics against liver fibrosis Ruchi Bansal has successfully received a Veni Grant of EUR 250,000 from The Netherlands Organisation for Scientific Research (NWO). The research project “Targeted Nanotherapeutics: Aiming at the resolution of Liver Fibrosis” will be conducted in the Department of Biomaterials Science and Technology.